Efficacy of Tegaserod in Relieving the Symptoms of Female Patients With Irritable Bowel Syndrome (IBS), Excluding Those With Predominant Diarrhea IBS

Clinical trial NCT00142987 · COMPLETED

Trial details

NCT number: NCT00142987
Sponsor: Novartis
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

IBS-C and IBS With Mixed Bowel Habits

Start date: 2004-04-01
Enrollment: 664

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.